Zorginstituut Nederland, which assesses the efficacy of new drugs and advises the government, says the drugs companies are effectively blackmailing officials by refusing to be transparent about their prices.
The analysis of the drug market in Kazakhstan revealed the shortcomings in procedures for the procurement of medicinal products, the facts of unjustified prescription of certain medicines by healthcare professionals.
In 2017, 5065.8 million packages of drugs worth 940.7 billion rubles (in retail prices) were sold through the pharmacies in Russia. This is 6.5% higher than in 2016 in value terms and 3.5% higher in physical terms.
In December 2017, the Russian commercial market of medicinal products was worth 69.3 billion rubles. Compared to November 2017, the market volume grew by 7.5%. On a year-over-year basis, the sales increased by 2.4%.